Objectives: Functional dyspepsia (FD) is a disorder of the gut-brain interaction characterized by epigastric pain, nausea, and/or early satiety. Existing literature suggests a physical link between psychiatric diagnoses and disorders of the gut-brain interaction at intestinal mast cells (MC) via corticotropin-releasing hormone (CRH) and its intestinally located receptors (CRHR1/CRHR2). Our study aimed to further clarify the physiologic connection between pediatric psychiatric illness and FD.
Methods: Study subjects were identified and classified into three groups. The FD group met Rome IV criteria and had insignificant gross endoscopic and histologic findings on gastric and duodenal biopsies. The control group reported no gastrointestinal symptoms or documented psychiatric illness. A third group consisted of Helicobacter pylori (HP)-positive dyspepsia patients independent of psychiatric history. Duodenal biopsy blocks were stained with antibodies targeting MCs, CRH, and CRHR1/CRHR2.
Results: We included 49 patients: 21 FD, nine controls, and 19 HP patients. We found a statistical difference between duodenal MC density in FD versus controls and HP versus controls (p < 0.05). We found no significant CRHR2 staining in the control group, yet the FD and HP groups yielded strong stains. We found a significant increase in MC density and CRHR2 staining in patients with a psychiatric history versus without (p < 0.05).
Conclusion: Our data show increased MC density and stronger CRHR2 staining in patients with FD and in patients with a psychiatric history. Our data support a pathophysiologic theory of FD development via a "gut-brain axis" intersecting at the level of MCs with influence via peripheral CRH.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jpn3.12477 | DOI Listing |
Endocr Metab Immune Disord Drug Targets
March 2025
Colorectal Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030000, China.
Aim: The purpose of this study was to identify molecular subtypes and hub genes in fibromyalgia [FM] based on immune-related genes [IRGs].
Background: FM is a chronic disease featuring widespread pain, and the immune system may be involved in the FM progression.
Objective: The objectives of this study are as follows: 1] To identify the molecular subtypes of FM based on IRGs.
J Neuroinflammation
March 2025
College of Acupuncture and Orthopedics, Hubei University of Chinese Medicine, Wuhan, 430061, China.
Chronic urticaria (CU) arises from a multifaceted interplay of immunological, neurological, and psychological components. Immune dysregulation, mediated through both immunoglobulin E (IgE)-dependent and IgE-independent pathways, plays a pivotal role in CU pathogenesis, involving key effector cells such as mast cells (MCs), basophils, and eosinophils. This dysregulation culminates in the release of histamine, prostaglandins, and other mediators, which precipitate pruritus.
View Article and Find Full Text PDFBMC Pharmacol Toxicol
March 2025
Department of Cardiology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, 121000, China.
Objective: The aim of this study was to investigate AMD1 cardiotoxicity function for Maduramicin (Mad).
Methods: SD rats were divided into control (Control) group and Mad treatment (3.5 mg/kg) group (Mad).
Cancer Cell
March 2025
Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA 02115, USA. Electronic address:
In this issue of Cancer Cell, Zhang et al. use single-cell RNA sequencing to compare immune cell dynamics in triple-negative breast cancers treated with the PD-L1 inhibitor atezolizumab plus paclitaxel or nab-paclitaxel. They identify distinct T cell activation patterns and highlight mast cells' role in immune activation exclusively in the nab-paclitaxel combination.
View Article and Find Full Text PDFNat Commun
March 2025
Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Overcoming immunosuppression in the tumor microenvironment (TME) is crucial for developing novel cancer immunotherapies. Here, we report that IL-16 administration enhances the polarization of T helper 1 (Th1) cells by inhibiting glutamine catabolism through the downregulation of glutaminase in CD4 T cells and increases the production of Th1 effector cytokine IFN-γ, thus improving anti-tumor immune responses. Moreover, we find that establishing an IL-16-dependent, Th1-dominant TME relies on mast cell-produced histamine and results in the increased expression of the CXCR3 ligands in tumor-associated macrophages (TAM), thereby improving the therapeutic effectiveness of immune checkpoint blockade (ICB).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!